key: cord-0296168-r9i7ox5f
authors: Suzuki, M.; Niimura, A.; Nakamura, Y.; Otsuka, Y.
title: A preliminary study of commercially available general-purpose chest radiography artificial intelligence-based software for detecting airspace opacity lesions in COVID-19 patients
date: 2021-12-29
journal: nan
DOI: 10.1101/2021.12.22.21268176
sha: 08472b116b300beb1fefe52b3145ab5595c18660
doc_id: 296168
cord_uid: r9i7ox5f

Purpose To validate commercially available general-purpose artificial intelligence (AI)-based software for detecting airspace opacity in chest radiographs (CXRs) of COVID-19 patients. Materials and Methods We used the ieee8023-covid-chestxray-dataset to validate commercial AI software capable of detecting "Nodule/Mass" and "Airspace opacity" as regions of interest with probability scores. From this dataset, we excluded computed tomography images and CXR images taken using an anteroposterior spine view and analyzed CXR images tagged with "Pneumonia/Viral/COVID-19" and "no findings". A radiologist then reviewed the images and rated them on a 3-point opacity score for the presence of airspace opacity. The maximum probability score of airspace opacity for each image was calculated using this software. The difference in each maximum probability for each opacity score was evaluated using Wilcoxon's rank sum test. The threshold of the probability score was determined by receiver operator characteristic curve analysis for the presence or absence of COVID-19, and the true positive rate (TPR) and false positive rate (FPR) were determined for the individual and overall opacity scores. Results Images from 342 patients with COVID-19 and 15 normal images were included. Opacity scores of 1, 2, and 3 were observed in 44, 70, and 243 images, respectively, of which 33 (75%), 66 (94.2%), and 243 (100%), respectively, were from COVID-19 patients. The overall TPR and FPR were 0.82 and 0.13, respectively, at an area under the curve of 0.88 and a threshold of 0.06, while the FPR for opacity score 1 was 0.18 and the TPR for score 3 was 0.97. Conclusion Using a public database containing CXR images of COVID-19 patients, commercial AI software was shown to be able to detect airspace opacity in severe pneumonia. Summary Commercially available AI software was capable of detecting airspace opacity in CXR images of COVID-19 patients in a public database.

Coronavirus disease 2019 (COVID-19) has spread worldwide. This pandemic caused a crisis-level shortage of hospital beds in many countries. In Japan, the number of positive cases per day reached 25,851 (20.6/100,000) on August 25, 2021, and the hospitalization rate decreased to 11.8% 1 . Therefore, there is an urgent need to establish a method for the appropriate allocation of medical resources.

Chest radiography (CXR) is expected to be an efficient triage tool for COVID-19 due to its low operational cost and high throughput. Although it is less sensitive than computed tomography (CT) for early detection of pneumonia 2 , it has been reported to be sufficiently sensitive for detecting severe disease and high-risk CXR findings such as bilateral opacities, multifocal opacities, and upper or middle zone opacities 3 . Moreover, artificial intelligence (AI)-based patient prognostic models have been reported 4, 5 and are expected to prove useful for clinical triage and workflow optimization.

In this study, we hypothesized that commercially available general-purpose AI software for CXR could detect airspace opacity in COVID-19 patients. As an initial study prior to a clinical study, we used the publicly available COVID-19 CXR database 6 to validate the software and examine its performance.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 29, 2021. ; https://doi.org/10.1101/2021.12.22.21268176 doi: medRxiv preprint

We used an anonymized public dataset 6 that has already been widely used for AI research 7,8 on COVID-19. In accordance with the ethical guidelines for medical and health sciences research involving human subjects 10,11 , no review by an institutional review board was required.

Because the dataset contains both CT and CXR images, we first extracted only CXR images. Second, we filtered suspected or confirmed COVID-19 positive patients and patients with no findings as controls. Third, we excluded images that tagged "AP supine views" because we were more interested in detecting imaging findings in asymptomatic to moderately ill patients than in detecting findings in images of patients with pre-existing severe pneumonia. Moreover, we excluded lateral-view images.

A radiologist with 17 years of experience independently rated the presence of airspace opacity on a 3-point scale based on confidence levels. The criteria were as follows: opacity confidence score 1, negative; opacity confidence score 2, indeterminate (including ground-glass opacity and suboptimal image quality); opacity confidence score 3, definite airspace opacity. In this preliminary study, we did not consider the zones containing shadows, the number of shadows, or the size of the shadows.

We used commercially available AI software (Plus.CXR; Plusman LLC, Tokyo, . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. where the ROIs exist. We also measured the cardiothoracic ratio as a reference value. Figure 1 shows a CXR image overlaid with the AI output results. Note that the threshold settings used for the display were disabled. The bounding box shows the name of the detected class, the probability score, and the zone where the shadow exists. Figure 1a shows an image with an opacity confidence score of 1 for visual evaluation, showing a pale infiltration to the frosted shadow. Figure 1b shows an image with an opacity confidence score of 2, which shows a dense airspace opacity shadow with bilateral upper lung zone predominance. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 29, 2021. ; https://doi.org/10.1101/2021.12.22.21268176 doi: medRxiv preprint medians and interquartile ranges (IQRs).

We assessed the differences in probability scores using Wilcoxon's test. P values of ≤ 0.05, were considered statistically significant. Receiver operator characteristic (ROC) curves were generated from the presence or absence of COVID-19 and probability scores for all images, and the area under the ROC curve (AUC) and threshold values were determined. The true positive rate (TPR) and the false positive rate (FPR) for the individual and overall capacity scores were calculated using the calculated thresholds.

Of the 950 images in the dataset, 866 were CXRs; from 504 COVID-19 and 18 normal images, 342 COVID-19 images and 15 normal images were finally available for analysis. Figure 2 shows the image selection flowchart and its breakdown.

Opacity confidence scores of 1, 2, and 3 were found in 44, 70, and 243 images, respectively, of which (75%), 66 (94.2%), and 243 (100%), respectively, were from patients with COVID-19. Figure 3 shows a box-and-whisker plot of the results of the quantitative and probability scores. The medians for overall and opacity confidence scores of 1, 2, and 3 were 0.35 (IQR: 0.11-0.55), 0.02 (IQR: 0.00-0.03), 0.11 (IQR: 0.04-0.25), and 0.47 (IQR: 0.33-0.59), respectively. There was a significant difference . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 29, 2021. ; https://doi.org/10.1101/2021.12.22.21268176 doi: medRxiv preprint between the probability scores of confidence scores 1, 2, and 3 (p < 0.001). Figure 4 shows the ROC curve generated for the diagnosis of COVID-19 using all images. The AUC was 0.88. Figure 5shows the heat map of the confusion matrix for all images and for those with scores of 1, 2, and 3 when the threshold was set to 0.06. The TPR and FPR for each score are shown in Table 1 .

During the COVID-19 pandemic, many countries experienced a depletion of medical resources, whose efficient distribution has become a challenge. Although CXR is reported to have a lower initial diagnostic sensitivity for COVID-19 than that associated with CT 2 , it is widely used for patient monitoring and screening because of its advantages such as the equipment's low cost and simplicity, transportability to the bedside, short imaging time, and ease of decontamination. In this study, we showed that COVID-19 lung lesions can be detected using commercially available AI software. We discuss whether this model can be used for efficient COVID-19 practice and the additional research needed to use it.

In this study, we showed that the presence of airspace opacity can be evaluated using the maximum probability score calculated by our model. The results also suggest . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. reported that the addition of clinical information improved the accuracy of prognostication. Our model adopted the former approach, and we believe that this approach is preferable during the COVID-19 pandemic.

We believe that there are two advantages to a model that uses radiologist-derived severity scores for learning. First, they can be "explainable AI." Because the interpretation of AI output results is ultimately the responsibility of humans, the task of image review by clinicians remains. Second, it is easy to create new models using existing models in a situation where factors that affect the clinical course, such as vaccination, antibody cocktail therapy, and mutant strains with different toxicities, emerge consecutively. It is expected that a model for extracting one-stop prognostic features from CXR using AI will need to be developed for each cohort. Conversely, it is relatively easy to create a new prognostic model by varying the threshold value of the model that extracts the probability and area of findings from images. This preliminary study had several limitations. First, we used public data. The image quality varied, and there were some missing clinical data. In fact, the team that created . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted December 29, 2021. ; https://doi.org/10.1101/2021.12.22.21268176 doi: medRxiv preprint this database advises not to use them to determine diagnostic performance 15 . However, because we used public data not used for training for validation, the impact of database bias 4 is expected to be small. Second, images were evaluated by a single person.

Although there is interobserver variability in the diagnosis of pneumonia 16 , in this study, each group of confidence scores by a single radiologist could be separated by AI-based probability scores with significant differences. The clinical significance of the overlap is unclear, but it is a potential consideration for future research. Third, we did not evaluate all the lesions extracted by our model. This is because there is no gold standard such as CT, and it is difficult to perform a detailed evaluation because of differences in the image quality and size compared to those of DICOM format images for diagnosis. This is an issue for consideration in future research.

In conclusion, our hypothesis that commercially available AI-based software could detect opacity regions in CXRs of COVID-19 patients was proved. We hope to conduct clinical research and develop a prognostic model using the output results of this AI to help in the treatment of COVID-19 infections.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Table 1 . TPR and FPR for all images and the images of opacity confidence score 1, 2, 3, respectively (threshold of probability score = 0.06) . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 29, 2021. ; https://doi.org/10.1101/2021.12.22.21268176 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 29, 2021. ; https://doi.org/10.1101/2021.12.22.21268176 doi: medRxiv preprint

Information on COVID-19 by the Ministry of Health

Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19

High-risk chest radiographic features associated with COVID-19 disease severity

Automated Assessment and Tracking of COVID-19 Pulmonary Disease Severity on Chest Radiographs Using Convolutional

Siamese Neural Networks

Efficacy of Chest Radiography as a Primary Care Triage Tool in Severe Coronavirus Disease

COVID-19 outbreak in Italy: experimental chest X-ray scoring system for quantifying and monitoring disease progression

We are building an open database of COVID-19 cases with chest X-ray or CT images

Interpretations of Mobile Chest Radiographs for Nursing Home-Acquired Pneumonia

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprintThe copyright holder for this this version posted December 29, 2021. ; https://doi.org/10.1101/2021.12.22.21268176 doi: medRxiv preprint